Home › Funds › Whetstone Capital Advisors, LLC › HCAT

Whetstone Capital Advisors, LLC position in HCAT

HEALTH CATALYST INC · Information Technology

Whetstone Capital Advisors, LLC reported holding 167,097 shares of HCAT (HEALTH CATALYST INC) in its Q2 2026 13F filing — a position valued at US$333K, representing 0.09% of its reported portfolio and ranking #41 among its reported holdings. Whetstone Capital Advisors, LLC has disclosed HCAT holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)167.10K sh
Reported value held$332.52K
Portfolio Weight0.09%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Whetstone Capital Advisors, LLC's HCAT position evolved

Whetstone Capital Advisors, LLC first disclosed a stake in HCAT in Q1 2025 at 1,705,072 shares (US$7.7M). The position peaked in Q2 2025 at 3,731,350 shares, worth US$14.1M. Across 6 filings, Whetstone Capital Advisors, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 167,097 shares valued at US$333K — a reduction of -1,347,903 shares quarter over quarter.. Notable position changes include a 119% increase in Q2 2025 (shares fell 24% over the following quarter), a 60% trim in Q1 2026 (shares rose 57% over the following quarter), a 89% trim in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.71M $7.72M New
Q2 2025 3.73M $14.07M Add
Q3 2025 3.73M $10.63M Hold
Q4 2025 3.75M $8.96M Add
Q1 2026 1.51M $1.92M Reduce
Q2 2026 167.10K $332.52K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HCAT and 13F data

HCAT (HEALTH CATALYST INC) is a Information Technology company. 8 other funds we track also report a position in HCAT — the largest reported positions include First Light Asset Management, LLC (US$25.5M), CDC Financial, Inc. (US$14.1M), Palogic Value Management, L.P. (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HCAT

All HCAT fund holders →

FAQ

How long has Whetstone Capital Advisors, LLC held HCAT?

Whetstone Capital Advisors, LLC has disclosed HCAT holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Whetstone Capital Advisors, LLC's current position in HCAT?

As of Q2 2026, Whetstone Capital Advisors, LLC holds 167.10K shares of HCAT (HEALTH CATALYST INC), valued at $332.52K, representing 0.09% of its reported portfolio and ranking #41.

Has Whetstone Capital Advisors, LLC been buying or selling HCAT?

In the latest 13F filing (Q2 2026), Whetstone Capital Advisors, LLC reduced its position in HCAT. The position peaked in Q2 2025 at 3.73M shares.

Which other funds hold HCAT?

Other major institutional holders of HCAT include First Light Asset Management, LLC, CDC Financial, Inc., Palogic Value Management, L.P., among 8 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.